Viscofan Balance Sheet Health
Financial Health criteria checks 5/6
Viscofan has a total shareholder equity of €932.5M and total debt of €243.1M, which brings its debt-to-equity ratio to 26.1%. Its total assets and total liabilities are €1.4B and €475.5M respectively. Viscofan's EBIT is €197.5M making its interest coverage ratio 48.4. It has cash and short-term investments of €64.7M.
Key information
26.1%
Debt to equity ratio
€243.11m
Debt
| Interest coverage ratio | 48.4x |
| Cash | €64.67m |
| Equity | €932.49m |
| Total liabilities | €475.55m |
| Total assets | €1.41b |
Recent financial health updates
Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Recent updates
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue
Dec 26Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report
Oct 26Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)
Oct 08Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing
Sep 25Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today
Aug 17Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 02Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue
Jun 26Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 20Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All
Apr 11Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?
Apr 04Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio
Mar 18Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement
Jan 17Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?
Nov 15Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 29Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?
Aug 11Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374
May 04Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Apr 24The Returns At Viscofan (BME:VIS) Aren't Growing
Mar 02Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Feb 16Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Returns On Capital At Viscofan (BME:VIS) Have Stalled
Nov 29Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price
Nov 11Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger
Aug 03Viscofan's (BME:VIS) Returns Have Hit A Wall
May 03Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?
Mar 06Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Jan 15Returns At Viscofan (BME:VIS) Appear To Be Weighed Down
Dec 29Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Nov 24Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?
Oct 10With EPS Growth And More, Viscofan (BME:VIS) Is Interesting
Sep 23Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 19Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Aug 03A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)
May 17Viscofan (BME:VIS) Could Easily Take On More Debt
Apr 07Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?
Mar 04Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like
Feb 17Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 02
A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Jan 18Why Viscofan's (BME:VIS) CEO Pay Matters
Dec 26Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon
Dec 13Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?
Dec 04The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come
Nov 19Financial Position Analysis
Short Term Liabilities: VIS's short term assets (€793.1M) exceed its short term liabilities (€336.8M).
Long Term Liabilities: VIS's short term assets (€793.1M) exceed its long term liabilities (€138.7M).
Debt to Equity History and Analysis
Debt Level: VIS's net debt to equity ratio (19.1%) is considered satisfactory.
Reducing Debt: VIS's debt to equity ratio has increased from 20.7% to 26.1% over the past 5 years.
Debt Coverage: VIS's debt is well covered by operating cash flow (87.5%).
Interest Coverage: VIS's interest payments on its debt are well covered by EBIT (48.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 12:07 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viscofan, S.A. is covered by 28 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| César Sánchez-Grande Bergon | Ahorro Corporación |
| José Rito | Banco BPI, S.A. |
| Sofia Rebuelta Villegas | Banco de Madrid S.A.U. |